FULC · CIK 0001680581 · operating
Fulcrum Therapeutics, Inc. (FULC) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $520 million, Fulcrum Therapeutics, Inc. is a small-cap company. The stock currently trades at $7.81, down 6.80% today, with a 52-week range of $2.31–$15.74.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.18 | $-1.18 | -637.5% | |
| 2024 | $-0.16 | $-0.16 | +89.9% | |
| 2023 | $-1.59 | $-1.59 | +34.8% | |
| 2022 | $-2.44 | $-2.44 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-24 | 0001193125-26-065197 | SEC ↗ |
| 2024-12-31 | 2025-02-25 | 0000950170-25-026068 | SEC ↗ |
| 2023-12-31 | 2024-02-27 | 0000950170-24-021074 | SEC ↗ |
| 2022-12-31 | 2023-03-09 | 0000950170-23-006841 | SEC ↗ |
| 2021-12-31 | 2022-03-03 | 0000950170-22-002727 | SEC ↗ |
| 2020-12-31 | 2021-03-04 | 0001564590-21-010715 | SEC ↗ |
| 2019-12-31 | 2020-03-05 | 0001564590-20-008951 | SEC ↗ |